• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析新冠疫情在18个主要国家中检测、确诊病例、死亡病例及死亡率的不平等分布情况。

Analyzing COVID-19 pandemic for unequal distribution of tests, identified cases, deaths, and fatality rates in the top 18 countries.

作者信息

Shams Shahbaz A, Haleem Abid, Javaid Mohd

机构信息

Department of Mechanical Engineering, Jamia Millia Islamia, New Delhi, India.

出版信息

Diabetes Metab Syndr. 2020 Sep-Oct;14(5):953-961. doi: 10.1016/j.dsx.2020.06.051. Epub 2020 Jun 26.

DOI:10.1016/j.dsx.2020.06.051
PMID:32604014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7318938/
Abstract

BACKGROUND AND AIMS

COVID-19 pandemic has affected various countries differently due to variance in demographics, income level, health infrastructure, government response, control and enforcement, and cultural traits of different populations. This study aims to identify significant factors behind the unequal distribution of identified cases and deaths in different countries. Our study's objective is comparative analysis and identification of relations between the spread of COVID-19 pandemic, population characteristics, and government response.

METHODS

The top 18 countries worst hit by COVID-19 cases were identified. The data metrics, such as the number of cases, deaths, fatality rates, tests, average life expectancy, and population, were collected and consolidated.

RESULTS

Countries with significant percentage of the older population are vulnerable to a high number of deaths due to COVID-19. Developed countries have higher per capita testing, whereas testing is less intensive in developing/underdeveloped countries. There is a consensus among health experts that COVID-19 has higher fatality rates for people above 60, however, with further age, this increases exponentially. Countries with higher life expectancy are also high-income countries, and the best course of action would be to provide specialized support to self-isolate for people of ages 75 and above.

CONCLUSION

The behaviour of disease occurring at a large scale and interaction with different populations is studied to understand and differentiate the factors and measures that successfully inhibited the pandemic. The study benchmarks different countries based on their performance and efforts against the pandemic and provides some useful insights on the efficiency of their governance and potential to improve & ramp up their programs. The economic status and existing healthcare infrastructure as they are the key factors in determining the country's ability to contain and minimize the losses from this pandemic.

摘要

背景与目的

由于不同国家人口结构、收入水平、卫生基础设施、政府应对措施、管控力度以及不同人群文化特征的差异,新冠疫情对各国的影响各不相同。本研究旨在确定不同国家确诊病例和死亡人数分布不均背后的重要因素。我们研究的目的是对新冠疫情传播、人口特征和政府应对措施之间的关系进行比较分析并加以识别。

方法

确定了受新冠病例影响最严重的18个国家。收集并整合了病例数、死亡数、死亡率、检测数、平均预期寿命和人口等数据指标。

结果

老年人口占比高的国家因新冠疫情易出现大量死亡病例。发达国家人均检测次数更多,而发展中/欠发达国家的检测力度较小。卫生专家一致认为,新冠疫情对60岁以上人群的死亡率更高,然而,随着年龄进一步增长,死亡率呈指数级上升。预期寿命较高的国家也是高收入国家,最佳行动方案是为75岁及以上人群提供专门的自我隔离支持。

结论

研究大规模发生的疾病行为及其与不同人群的相互作用,以了解和区分成功抑制疫情的因素和措施。该研究根据不同国家抗击疫情的表现和努力进行基准对比,并对其治理效率以及改进和加强相关计划的潜力提供了一些有益见解。经济状况和现有的医疗基础设施是决定一个国家控制疫情并将疫情损失降至最低能力的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/fc208d948a14/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/7555daf40f0a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/57bb9e5ec48b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/d1fbabc59a92/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/547c8035703b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/6913f37557c1/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/fc208d948a14/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/7555daf40f0a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/57bb9e5ec48b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/d1fbabc59a92/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/547c8035703b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/6913f37557c1/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7e/7318938/fc208d948a14/gr6_lrg.jpg

相似文献

1
Analyzing COVID-19 pandemic for unequal distribution of tests, identified cases, deaths, and fatality rates in the top 18 countries.分析新冠疫情在18个主要国家中检测、确诊病例、死亡病例及死亡率的不平等分布情况。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):953-961. doi: 10.1016/j.dsx.2020.06.051. Epub 2020 Jun 26.
2
Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.严重急性呼吸综合征冠状病毒2诊断检测特刊及本次大流行的经验教训
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01324-20.
3
Testing for SARS-CoV-2 (COVID-19): A General Review.严重急性呼吸综合征冠状病毒2(新冠病毒)检测:综述
R I Med J (2013). 2020 Sep 4;103(8):20-23.
4
SARS-CoV-2 diagnostic testing in Africa: needs and challenges.非洲的新型冠状病毒肺炎诊断检测:需求与挑战
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4. doi: 10.11604/pamj.2020.35.4.22703. eCollection 2020.
5
COVID-19: Diagnostic Testing and Challenges.新型冠状病毒肺炎:诊断检测与挑战
Crit Care Nurs Q. 2020 Oct/Dec;43(4):343-348. doi: 10.1097/CNQ.0000000000000320.
6
Assumptions for disparities in case-fatality rates of coronavirus disease (COVID-19) across the globe.全球范围内冠状病毒病(COVID-19)病死率差异的假设。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5180-5182. doi: 10.26355/eurrev_202005_21215.
7
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
8
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
9
Effect of heat and humidity on the incidence and mortality due to COVID-19 pandemic in European countries.热湿对欧洲国家 COVID-19 大流行发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9216-9225. doi: 10.26355/eurrev_202009_22874.
10
COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).2019冠状病毒病,澳大利亚:流行病学报告16(截至澳大利亚东部标准时间2020年5月17日23:59的报告周)
Commun Dis Intell (2018). 2020 May 22;44. doi: 10.33321/cdi.2020.44.45.

引用本文的文献

1
Exploring affordable and effective pandemic containment measures in lower-income countries with a spatial SEIR model: a case study in South Africa.运用空间SEIR模型探索低收入国家经济适用且有效的疫情防控措施:以南非为例
BMC Public Health. 2025 Jul 23;25(1):2526. doi: 10.1186/s12889-025-23686-0.
2
Application and significance of SIRVB model in analyzing COVID-19 dynamics.SIRVB模型在分析新型冠状病毒肺炎动态变化中的应用及意义
Sci Rep. 2025 Mar 12;15(1):8526. doi: 10.1038/s41598-025-90260-4.
3
Application and Significance of SIRVB Model in Analyzing COVID-19 Dynamics.

本文引用的文献

1
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).新型冠状病毒肺炎(COVID-19)感染患者临床表现及管理中的争议问题与不断演变的概念,涉及合并疾病(高血压、糖尿病等)治疗中使用的治疗性药物及其他药物的应用
Diabetes Metab Syndr. 2020 May-Jun;14(3):251-254. doi: 10.1016/j.dsx.2020.03.012. Epub 2020 Mar 25.
2
Clinical considerations for patients with diabetes in times of COVID-19 epidemic.2019冠状病毒病疫情期间糖尿病患者的临床考量
Diabetes Metab Syndr. 2020 May-Jun;14(3):211-212. doi: 10.1016/j.dsx.2020.03.002. Epub 2020 Mar 10.
3
SIRVB模型在分析新冠疫情动态中的应用及意义
medRxiv. 2024 Sep 23:2024.09.21.24314129. doi: 10.1101/2024.09.21.24314129.
4
PatCen: A blockchain-based patient-centric mechanism for the granular access control of infectious disease-related test records.基于区块链的以患者为中心的传染病相关检测记录细粒度访问控制机制
PLoS One. 2024 Sep 18;19(9):e0310407. doi: 10.1371/journal.pone.0310407. eCollection 2024.
5
Constructing a Learning Curve to Discuss the Medical Treatments and the Effect of Vaccination of COVID-19.构建学习曲线以探讨新冠病毒病的医学治疗及疫苗接种效果。
Healthcare (Basel). 2023 May 29;11(11):1591. doi: 10.3390/healthcare11111591.
6
Analyzing COVID-19 mortality in Ernakulam district of Kerala: A retrospective review of death reports.分析喀拉拉邦埃纳库卢姆区的新冠肺炎死亡率:死亡报告的回顾性研究
J Family Med Prim Care. 2022 Oct;11(10):6209-6214. doi: 10.4103/jfmpc.jfmpc_648_22. Epub 2022 Oct 31.
7
The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types on All-Cause Mortality: A Case-Series Retrospective Study.人口统计学、临床特征及各种新冠病毒变异类型对全因死亡率的影响:一项病例系列回顾性研究
Diseases. 2022 Nov 7;10(4):100. doi: 10.3390/diseases10040100.
8
Association between the Human Development Index and Confirmed COVID-19 Cases by Country.按国家划分的人类发展指数与确诊的新冠肺炎病例之间的关联。
Healthcare (Basel). 2022 Jul 29;10(8):1417. doi: 10.3390/healthcare10081417.
9
Sustained ethical analysis of global dilemmas and country-level decision making during and post the COVID-19 pandemic: A systematic review.对新冠疫情期间及之后全球困境和国家层面决策进行持续的伦理分析:一项系统综述。
Pak J Med Sci. 2022 Mar-Apr;38(4Part-II):1056-1063. doi: 10.12669/pjms.38.4.4755.
10
Generalized Susceptible-Exposed-Infectious-Recovered model and its contributing factors for analysing the death and recovery rates of the COVID-19 pandemic.用于分析新冠疫情死亡率和康复率的广义易感-暴露-感染-康复模型及其影响因素。
Appl Soft Comput. 2022 Jul;123:108973. doi: 10.1016/j.asoc.2022.108973. Epub 2022 May 11.
The COVID-19 epidemic.
新冠疫情。
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.